ValiRx Balance Sheet Health
Financial Health criteria checks 4/6
ValiRx has a total shareholder equity of £3.5M and total debt of £17.0K, which brings its debt-to-equity ratio to 0.5%. Its total assets and total liabilities are £3.7M and £187.7K respectively.
Key information
0.5%
Debt to equity ratio
UK£17.00k
Debt
| Interest coverage ratio | n/a |
| Cash | UK£809.15k |
| Equity | UK£3.50m |
| Total liabilities | UK£187.71k |
| Total assets | UK£3.69m |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: VAL's short term assets (£1.2M) exceed its short term liabilities (£181.1K).
Long Term Liabilities: VAL's short term assets (£1.2M) exceed its long term liabilities (£6.7K).
Debt to Equity History and Analysis
Debt Level: VAL has more cash than its total debt.
Reducing Debt: VAL's debt to equity ratio has reduced from 6.4% to 0.5% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: VAL has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: VAL has less than a year of cash runway if free cash flow continues to grow at historical rates of 11.5% each year.